Jun 14, 2022 / 05:40PM GMT
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity Analyst
All right. I think we're ready to get going here with our next session here at Goldman Sachs Healthcare Conference. I'm Amit Hazan, the medical technology analyst at Goldman, and we're really excited for the next conversation.
We've got Baxter with us today. We've got both Joe Almeida, the Chief Executive Officer with us; and as always, Clare Trachtman, the Vice President of Investor Relations.
So first and foremost, really excited to see you live and in person doing this back again. It's been virtual with you all in the last couple of years. So really nice to see you.
And not surprisingly, at this conference, a lot of the conversations have been around the macro and how that's evolving. And so I thought we would start with that with you as well and try to get through that, and then get into the business as well.
Questions and Answers:
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity AnalystAnd just start with manufacturing and supply
Trustpilot
